Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I–II papillary serous endometrial cancer-Reference-Cited by-同舟云学术

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I–II papillary serous endometrial cancer

Published:2012-11 Issue:2 Volume:127 Page:321-325
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kiess Ana P.,Damast Shari,Makker Vicky,Kollmeier Marisa A.,Gardner Ginger J.,Aghajanian Carol,Abu-Rustum Nadeem R.,Barakat Richard R.,Alektiar Kaled M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference22 articles.

1. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review;Boruta;Gynecol Oncol,2009

2. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers;Hamilton;Br J Cancer,2006

3. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy;Huh;Gynecol Oncol,2003

4. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma;Fader;Cancer,2009

5. Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes;Fader;Gynecol Oncol,2009

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinico pathological features and survival in serous endometrial cancers;Gynecologic Oncology Reports;2023-06

2. Endometrial Cancer;Fundamentals of Cancer Detection, Treatment, and Prevention;2022-05-13

3. Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes;Journal of Obstetrics and Gynaecology Research;2022-04-06

4. Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression;Oncogene;2022-02-10

5. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma;Cancer Treatment and Research Communications;2022